James D Phelan

7PUBLICATIONS
54CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 18, 2025
BLIMP1 negatively regulates IL-2 signaling in T cells.

Suyasha Roy, Min Ren, Peng Li

|Jul 18, 2024
Gα13 restricts nutrient driven proliferation in mucosal germinal centers.

Hang T Nguyen, Moyi Li, Rahul Vadakath

|Apr 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma.

Sean R Corcoran, James D Phelan, Jaewoo Choi

|Apr 18, 2024
Primary large B-cell lymphomas of immune-privileged sites.

Mark Roschewski, James D Phelan, Elaine S Jaffe

|May 04, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.

Sebastian Scheich, Jiji Chen, Jiamin Liu

|Aug 05, 2022
BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine.

James D Phelan, Thomas Oellerich

Pageof 2

Frequent Collaborators

3 joint publications

Jagan R Muppidi

3 joint publications

Thomas Oellerich

2 joint publications

Sean R Corcoran

2 joint publications

Henning Urlaub